TRIVENI - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.1
| Stock Code | TRIVENI | Market Cap | 7,484 Cr. | Current Price | 343 ₹ | High / Low | 468 ₹ |
| Stock P/E | 23.7 | Book Value | 141 ₹ | Dividend Yield | 0.73 % | ROCE | 9.01 % |
| ROE | 8.32 % | Face Value | 1.00 ₹ | DMA 50 | 369 ₹ | DMA 200 | 370 ₹ |
| Chg in FII Hold | 1.26 % | Chg in DII Hold | 0.16 % | PAT Qtr | 109 Cr. | PAT Prev Qtr | 31.9 Cr. |
| RSI | 33.8 | MACD | -9.76 | Volume | 5,87,855 | Avg Vol 1Wk | 4,23,616 |
| Low price | 305 ₹ | High price | 468 ₹ | PEG Ratio | -1.71 | Debt to equity | 0.17 |
| 52w Index | 23.1 % | Qtr Profit Var | 92.0 % | EPS | 13.7 ₹ | Industry PE | 11.3 |
📊 TRIVENI shows moderate fundamentals with ROE (8.32%) and ROCE (9.01%) that are below ideal levels, indicating limited efficiency. The P/E (23.7) is slightly above the industry average (11.3), suggesting relative overvaluation. Dividend yield is modest at 0.73%. EPS (13.7 ₹) is reasonable, and quarterly PAT surged (109 Cr. vs 31.9 Cr., +92%), showing strong earnings recovery. However, the PEG ratio (-1.71) highlights weak growth prospects. Technical indicators (RSI 33.8, MACD -9.76) show bearish momentum, with the stock trading below both 50 DMA (369 ₹) and 200 DMA (370 ₹).
💰 Ideal Entry Price Zone: Investors can consider accumulating between 320–340 ₹, near current support levels. A deeper value entry would be closer to 300–310 ₹ if weakness persists.
📈 Exit Strategy / Holding Period: For existing holders, TRIVENI is a fair candidate for medium-term holding (2–4 years) given its earnings recovery. Partial profit booking can be considered near 370–380 ₹ (DMA zone). Long-term holding is less attractive unless ROE and ROCE improve significantly.
✅ Positive
- Quarterly PAT surged (109 Cr. vs 31.9 Cr.), showing strong earnings recovery.
- EPS of 13.7 ₹ indicates profitability.
- Low debt-to-equity ratio (0.17), ensuring financial stability.
- FII holdings increased (+1.26%), showing foreign investor confidence.
⚠️ Limitation
- Weak ROE (8.32%) and ROCE (9.01%).
- PEG ratio negative (-1.71), indicating poor growth prospects.
- Dividend yield modest at 0.73%.
- Stock trading below both 50 DMA and 200 DMA, reflecting weakness.
📉 Company Negative News
- Technical weakness: RSI oversold (33.8), MACD negative (-9.76).
- Valuation higher than industry average (P/E 23.7 vs 11.3).
📈 Company Positive News
- Quarterly PAT growth strong (+92%).
- FII holdings increased, reflecting foreign investor confidence.
- EPS supports profitability despite weak efficiency metrics.
🏭 Industry
- Industry PE is 11.3, lower than TRIVENI’s valuation, highlighting relative overpricing.
- Sector benefits from industrial demand but faces margin pressures.
🔎 Conclusion
TRIVENI is a moderately strong company with improving profitability but weak efficiency metrics and stretched valuations compared to industry peers. Ideal entry is near 320–340 ₹, with a medium-term holding horizon of 2–4 years. Existing investors should continue holding cautiously, with partial profit booking near 370–380 ₹ if valuations stretch. Long-term holding is less attractive unless ROE and ROCE improve significantly.